Terug
Dr. S. Mook
Radiotherapeut-oncoloog
BIG nr. 89061228401
Aandachtsgebieden uitklapper, klik om te openen
- Gastro-intestinale tumoren
- Mammacarcinoom
Wetenschappelijk onderzoek uitklapper, klik om te openen
- Slokdarmkanker
- MRI-gestuurde radiotherapie
Publicaties uitklapper, klik om te openen
Key publications
- Mook S, Van 't Veer LJ, Rutgers EJ, Ravdin PM, van de Velde AO, van Leeuwen FE, Visser O, Schmidt MK. Independent prognostic value of screen detection in invasive breast cancer. J Natl Cancer Inst. 2011 Apr 6;103(7):585-97.
- Mook S, Schmidt MK, Rutgers EJ, van de Velde AO, Visser O, Rutgers SM, Armstrong N, van ’t Veer LJ, Ravdin PM. Calibration and discriminatory accuracy of the web-based tool Adjuvant! in a cohort of 5380 Dutch breast cancer patients. Lancet Oncol. 2009 Nov;10(11):1070-6.
- Mook S, Schmidt MK, Viale G, Pruneri G, Eekhout I, Floore A, Glas AM, Bogaerts J, Cardoso F, Piccart-Gebhart MJ, Rutgers ET, Van't Veer LJ; On behalf of the TRANSBIG consortium. The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study. Breast Cancer Res Treat. 2009 Jul;116(2):295-302.
- Mook S, Bonnefoi H, Pruneri G, Larsimont D, Jaskiewicz J, Sabadell MD, Macgrogan G, Van't Veer LJ, Cardoso F, Rutgers EJ. Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial. Eur J Cancer. 2009 May;45(7):1201-8.